Abstract
The blood level of erythropoietin (Epo) is often anomalously low in anemic patients with inflammatory or malignant diseases. Therefore, we studied effects of pure recombinant immunomodulatory peptides on Epo formation in cultures of the human hepatoma cell line, HepG2. Interleukin (IL)-1β, IL-1α, and tumor necrosis factor α lowered Epo production with half-maximal inhibition at 2, 5, and 20 U/ml, respectively. IL-6, transforming growth factor β2 and interferon γ did not inhibit. Furthermore, IL-1β (10 U/ml) proved to block Epo formation in isolated serum-free perfused rat kidneys. Proposedly, monokines play a role in the pathogenesis of Epo deficiency in various diseases.
| Originalsprache | Englisch |
|---|---|
| Zeitschrift | Life Sciences |
| Jahrgang | 50 |
| Ausgabenummer | 4 |
| Seiten (von - bis) | 301-308 |
| Seitenumfang | 8 |
| ISSN | 0024-3205 |
| DOIs | |
| Publikationsstatus | Veröffentlicht - 1992 |
Fördermittel
This work was supported by the Deutsche Forschungsgemeinschaff (DFG Je 95/6). The authors would like to thank Mrs. Elisabeth Mauch and Mrs. Karin Piccardi for expert technical assistance and Mrs. Ursula Isenberg for secretarial assistance.
UN SDGs
Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung
-
SDG 3 – Gesundheit und Wohlergehen
Strategische Forschungsbereiche und Zentren
- Forschungsschwerpunkt: Gehirn, Hormone, Verhalten - Center for Brain, Behavior and Metabolism (CBBM)
Fingerprint
Untersuchen Sie die Forschungsthemen von „Monokines inhibiting erythropoietin production in human hepatoma cultures and in isolated perfused rat kidneys“. Zusammen bilden sie einen einzigartigen Fingerprint.Zitieren
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver